Publications by authors named "Teemu D Laajala"

Claim this Profile
C
Comparable recurrence risk for MRI-detected Gleason Grade Group (GG) 2 and systematic biopsy-detected GG1 prostate cancer.
Abderrahim-Oussama Batouche, Eugen Czeizler, Timo-Pekka Lehto, Andrew Erickson, Tolou Shadbahr, Teemu D Laajala

BJU Int· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Competing risk of death in patients with low, intermediate and high risk of recurrence after radical surgery for clear cell renal cell carcinoma.
Anna Brännbäck, Ivan Mustonen, Teemu D Laajala, Paula Vainio, Magnus Lindskog

BJUI Compass· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer.
Majid Momeny, Mari Tienhaara, Mukund Sharma, Deepankar Chakroborty, Roosa Varjus, Teemu D Laajala

EMBO Mol Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NPEPPS Is a Druggable Driver of Platinum Resistance.
Robert T Jones, Mathijs Scholtes, Andrew Goodspeed, Maryam Akbarzadeh, Saswat Mohapatra, Teemu D Laajala

Cancer Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
ProstaMine: a bioinformatics tool for identifying subtype-specific co-alterations associated with aggressiveness in prostate cancer.
Michael V Orman, Varsha Sreekanth, Teemu D Laajala, Scott D Cramer, James C Costello

Front Pharmacol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer.
Mike Mason, Óscar Lapuente-Santana, Anni S Halkola, Wenyu Wang, Raghvendra Mall, Teemu D Laajala

J Transl Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low nuclear expression of HIF-hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence-free survival in clear cell renal cell carcinoma.
Lassi Luomala, Kalle Mattila, Paula Vainio, Harry Nisén, Teijo Pellinen, Teemu D Laajala

Cancer Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRI-Targeted Prostate Biopsy Introduces Grade Inflation and Overtreatment.
Abderrahim Oussama Batouche, Eugen Czeizler, Timo-Pekka Lehto, Andrew Erickson, Tolou Shadbahr, Teemu Daniel Laajala

medRxiv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbiome-based risk prediction in incident heart failure: a community challenge.
Pande Putu Erawijantari, Ece Kartal, José Liñares-Blanco, Teemu D Laajala, Lily Elizabeth Feldman

medRxiv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of a Fish Oil and/or Probiotic Intervention from Early Pregnancy Onwards on Colostrum Immune Mediators: A Randomized, Placebo-Controlled, Double-Blinded Clinical Trial in Overweight/Obese Mothers.
Jenni Soukka, Lauri Polari, Marko Kalliomäki, Lotta Saros, Teemu D Laajala

Mol Nutr Food Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A harmonized resource of integrated prostate cancer clinical, -omic, and signature features.
Teemu D Laajala, Varsha Sreekanth, Alex C Soupir, Jordan H Creed, Anni S Halkola

Sci Data· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotic Treatment is an Independent Poor Risk Factor in NSCLC But Not in Melanoma Patients Who had Received Anti-PD-1/L1 Monotherapy.
Hannes Vihinen, Artturi Jokinen, Teemu D Laajala, Nesna Wahid, Lotta Peltola

Clin Lung Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Female doping: observations from a data lake study in the Hospital District of Helsinki and Uusimaa, Finland.
Paula Katriina Vauhkonen, Teemu Daniel Laajala, Katarina Mercedes Lindroos, Mikko Ilari Mäyränpää

BMC Womens Health· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin.
Florus C de Jong, Teemu D Laajala, Robert F Hoedemaeker, Kimberley R Jordan, Angelique C J van der Made

Sci Transl Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OSCAR: Optimal subset cardinality regression using the L0-pseudonorm with applications to prognostic modelling of prostate cancer.
Anni S Halkola, Kaisa Joki, Tuomas Mirtti, Marko M Mäkelä, Tero Aittokallio, Teemu D Laajala

PLoS Comput Biol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
curatedPCaData: Integration of clinical, genomic, and signature features in a curated and harmonized prostate cancer data resource.
Teemu D Laajala, Varsha Sreekanth, Alex Soupir, Jordan Creed, Federico Cf Calboli

bioRxiv· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246-Sensitive Disease Subtype.
Anna N Cvrljevic, Umar Butt, Kaisa Huhtinen, Tove J Grönroos, Camilla Böckelman, Teemu D Laajala

Mol Cancer Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High intratumoral dihydrotestosterone is associated with antiandrogen resistance in VCaP prostate cancer xenografts in castrated mice.
Riikka Huhtaniemi, Petra Sipilä, Arttu Junnila, Riikka Oksala, Matias Knuuttila, Teemu D Laajala

iScience· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes.
Lauren K Jillson, Gabriel A Yette, Teemu D Laajala, Wayne D Tilley, James C Costello

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A three-feature prediction model for metastasis-free survival after surgery of localized clear cell renal cell carcinoma.
Kalle E Mattila, Teemu D Laajala, Sara V Tornberg, Tuomas P Kilpeläinen, Paula Vainio

Sci Rep· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A relational database to identify differentially expressed genes in the endometrium and endometriosis lesions.
Michael Gabriel, Vidal Fey, Taija Heinosalo, Prem Adhikari, Kalle Rytkönen, Teemu Daniel Laajala

Sci Data· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1.
Otto Kauko, Susumu Y Imanishi, Evgeny Kulesskiy, Laxman Yetukuri, Teemu Daniel Laajala

J Biol Chem· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploratory Analysis of CA125-MGL and -STn Glycoforms in the Differential Diagnostics of Pelvic Masses.
Liina Salminen, Nimrah Nadeem, Anne Lone Rolfsen, Anne Dørum, Teemu D Laajala

J Appl Lab Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effective survival prediction for patients with advanced prostate cancer using clinical trial and real-world hospital registry datasets.
Mika Murtojärvi, Anni S Halkola, Antti Airola, Teemu D Laajala, Tuomas Mirtti

Int J Med Inform· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling genetic heterogeneity of drug response and resistance in cancer.
Teemu D Laajala, Travis Gerke, Svitlana Tyekucheva, James C Costello

Curr Opin Syst Biol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis